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Objectives. The overall benefit of carotid endarterectomy (CEA) is dependent on the outcome from the procedure. However,
many reports are from selected centres and not population-based. The aim of this study was to assess the 30-day complication
rate for a whole country and also to determine independent risk factors for serious complications.
Materials and methods.One thousand five hundred and eighteen CEAwere retrospectively reviewed, covering principally
all the CEAs in Sweden, during a three year period. Indications for surgery were; minor stroke 34%, TIA 34%, amaurosis
fugax 18%, asymptomatic 11% and others 3%. Data were collected from the Swedish Vascular Registry (Swedvasc).
Combined cohort and case–control methodology was used.
Results. Registered complications were; 43 permanent strokes, 32 transient strokes (,30 days), 18 TIA/amaurosis fugax
and 22 deaths (seven fatal stokes). In the cohort study, the 30-day permanent stroke and death rate were 4.3% (65/1518).
Significant risk factors in multivariate analyses were the indication for surgery (minor stroke vs. other indications)
(p ¼ 0.02, RR ¼ 1.38), diabetes (p ¼ 0.02, RR ¼ 1.41), cardiac disease (p , 0.01, RR 1.43) and operation at a university
hospital (p ¼ 0.02, RR ¼ 1.39). In the case–control study comparing the 65 cases of permanent stroke and/or death with
130 matched controls the only significant risk factor was contralateral occlusion (p , 0.01, OR ¼ 5.27). One patient
(1/130) with a permanent stroke was wrongly reported as a local neurological complication (facial paresis).
Conclusion. This national audit demonstrated population-based data on complication rates after CEAwell comparable with
previous randomised trials. The validity of the Swedvasc data was confirmed. Combined cohort and case–control
methodology was useful in analysing risk factors for serious perioperative complications.
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Introduction
The efficacy of carotid endarterectomy (CEA) in
reducing the risk of subsequent stroke for recently
symptomatic severe carotid disease is well documen-
ted in randomised studies,1–4 but the outcome of the
procedure is highly dependent on the operative risk.
However, concerns have been expressed that the
results of these influential trials may not be attained in
the routine clinical setting.
Population-based data on complication rates after
CEA would make it possible to assess the effect of
implementation of guidelines based on these trials, but
most reports are on community or hospital data, and
study design as well as complication rates vary
considerably. Avalidated national audit could provide
important information regarding the overall benefit of
CEA for the population.
The Swedish Vascular Registry (Swedvasc) covers
from 1994 basically the whole Swedish population of
8.5 millions and has been validated.5
Based on data from Swedvasc concerning CEA, this
study aimed to assess the 30-day complication rate for
a whole country and also to determine independent
risk factors for serious complications.
Materials and Methods
All registered carotid endarterectomies in Swedvasc
during a three year period were retrospectively
reviewed. From January 1994, the first year Swedvasc
covered all centres performing CEA, until December
1996 a total of 1518 CEAs on 1411 patients were
reported. Carotid surgery was centralized to 20 of the
41 institutions that performed elective vascular
surgery.
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Swedvasc
Swedvasc contains prospectively registered basic
demographic data, comorbidity, operative risk factors
(ASA scoring system) and indications together with
information on surgical details and postoperative
complications. The protocol has been described in
details by others.5
Registered comorbidity and preoperative risk fac-
tors are listed in Table 1. The indications for surgery
were; minor stroke 34% (520/1518), TIA 34% (514/
1518), amaurosis fugax 18% (276/1518), asymptomatic
11% (166/1518) and others 3% (42/1518). The majority
with asymptomatic indication was included in the
European asymptomatic carotid trial (ACST).
Follow-up
Follow-up was performed 30 days after the operation
by a surgeon or neurologist. All neurological events,
regardless if ipsilateral or contralateral to the endar-
terectomy and all deaths regardless of cause were
registered. Postoperative neurological morbidity was
classified as TIA, transient stroke (deficit .24 h but
,30 days) and permanent stroke.
To analyse risk factors a combined cohort and case–
control study design was used.
Cohort study
All reported permanent stroke and deaths were
identified, complete records were requested and
analyzed by independent members of the Carotid
Review Committee.6
Case–control study
For every case of permanent stroke or death, two
controls, matched for operating centre, surgical indi-
cation and age, were randomly selected. Patient
records were reviewed by an independent non-
surgical observer in an effort to study variables not
addressed in the Swedvasc protocol and in order to
look for discrepancies in data entry and reported
outcome.
Statistics
Statistical analyses were performed using the SPSS for
Windows program package. Categorical variables
were compared with x2-test or Fisher’s exact test and
continuous variables with Student’s t-test or Mann–
Whitney-U test depending on the distribution of the
variable. All tests were two tailed and level of
significance set at p , 0:05: Preoperative variables
that were positively associated with postoperative
outcome at p , 0:1 were selected for multivariate
analysis using logistic regression. Relative risk (RR) for
the cohort part of the study and odds ratio (OR) for the
case–control part was calculated when possible.
Results
Cohort study
One thousand five hundred and eighteen CEAs were
included. Themean patient age was 68.8 (range 53–90)
years, and 65.5% (994/1518) were men. A patch was
used in 29.1% (436/1518).
Eight of the 20 centres were university hospitals,
performing 59% (897/1518) of the operations. The
mean annual caseload during the period at different
centers was:,10 in four hospitals, 10–20 in seven, 21–
30 in five, 31–50 in three and .100 in one only.
Registered 30-days complications are shown in
Table 2; including 43 permanent strokes, 32 transient
strokes, 18 TIA/amaurosis fugax and 22 deaths.
Causes of the 22 deaths were 13 cardiac, seven strokes,
one ruptured aortic aneurysm and one pneumonia.
The statistics of the risk factors are listed in Tables
3–5, with independent risk factors (and complication
rates) as follows.
Table 1. Comorbidity and preoperative risk factors
No. %
Cardiac disease (unspecified) 678 44.7
Hypertension 789 52.0
Previous vascular surgery 288 19.0
Diabetes mellitus 209 13.8
Chronic obstructive pulmonary disease 91 6.0
Renal disease, creatinine . 150 mmol/l 52 3.2
Smoking 574 37.8
Table 2. 30-Day complications
No. %
Permanent stroke 43 2.8
Transient stroke 32 2.1
TIA/amaurosis fugax 18 1.2
Death 22 1.4
Cardiovascular 50 3.3
Local neurology 105 6.9
Haematoma/haemorrhage 94 6.2
Wound infection 15 1.0
Pulmonary 27 1.8
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(I)Permanent/fatal stroke (3.3% 50/1518) with
independent risk factors; indication for surgery
(minor stroke vs. other indications) (p ¼ 0:02;
RR ¼ 1.46) and previous vascular surgery
(p ¼ 0:03; RR ¼ 1.43).
(II)Death (1.4% 22/1518) with independent risk
factors; age .75 years (p , 0:05; RR ¼ 1.56),
diabetes (p , 0:01; RR ¼ 2.03), cardiac disease
(p , 0:01; RR ¼ 2.01) and operation at a university
hospital (p ¼ 0:01; RR ¼ 2.21).
(III)Combined permanent stroke and death (4.3%
65/1518) with independent risk factors; indication
for surgery (minor stroke vs. other indications)
(p ¼ 0:02; RR ¼ 1.38), diabetes (p ¼ 0:02;
RR ¼ 1.41), cardiac disease (p , 0:01; RR 1.43)
and operation at a university hospital (p ¼ 0:02;
RR ¼ 1.39).
There was no significant correlation between the
annual caseload of the centre and complication rates
(Spearmans’corr r ¼ 0:03; p ¼ 0:17). The use of patch
did not influence the complication rate ðp ¼ 0:70Þ:
Case–control study
In this series, there were 65 cases of permanent stroke or
death, compared with 130 controls (without serious
complications but matched for operating center, indi-
cation and age). Risk factors chosen for comparison,
together with statistic analyses, are presented in Table 6.
Contralateral occlusion, present in 15/65 cases and
7/130 controls, was the only statistically significant
factor (p , 0:01; OR ¼ 5.3 (95% confidence interval
2.02–13.07)) and remained as a risk factor also after
correction for the use of shunt.
Most procedures were performed under general
anaesthesia (49/65 cases and 91/130 controls) but the
technique of anaesthesia did not influence the out-
come ðp ¼ 0:43Þ: Likewise; stenosis degree, operative
bleeding, shunt, distal tacking suture, occlusion- and
operative time all failed to correlate with a significant
increase or decrease in operative risk.
In the process of reviewing patient reports the
independent observer found; one patient (1/130) with
a transient stroke not registered and, one patient
(1/130) with a permanent stroke misjudged as a local
Table 3. Risk factors for perioperative permanent or fatal stroke N 5 50=1518 (3.3%)
Risk factor Univariate analysis Multivariate analysis
p RR (95% confidence interval) p RR (95% confidence interval)
Operation at a university hospital 0.55* 1.23 (0.70–2.17)
Indication (minor stroke vs. other indications) 0.04** 1.38 (1.01–1.90) 0.019 1.46 (1.06–2.01)
Age .75 years 0.58* 1.20 (0.63–2.26)
Male 0.94* 1.02 (0.58–1.82)
Diabetes 0.09* 1.77 (0.92–3.39) 0.17 NS
Hypertension 0.24* 1.39 (0.79–2.42)
Cardiac (unspecified) 0.10* 1.58 (0.91–2.73 0.20 NS
Previous vascular surgery 0.10* 1.66 (0.91–3.04) 0.027 1.43 (1.04–1.98)
Chronic pulmonary disease 0.36***
Renal insufficiency 0.41***
Smoking 0.08* 0.58 (0.31–1.08) 0.83 NS
*, x2; **, Mann–Whitney-U test; ***, Fisher’s exact test.
Table 4. Risk factors for perioperative death N 5 22=1518 (1.4%)
Risk factor Univariate analysis Multivariate analysis
p RR (95% confidence interval) P RR (95% confidence interval)
Operation at a university hospital 0.008*** 4.38 (1.30–14.75) 0.01 2.21(1.19–4.09)
Indication (minor stroke vs. other indications) 0.18** 1.39 (0.86–2.23)
Age .75 years 0.03*** 2.62 (1.13–6.08) 0.049 1.56(1.00–2.42)
Male 0.12*** 2.37 (0.81–6.97) 0.09 NS
Diabetes 0.006*** 3.58 (1.52–8.43) 0.002 2.03 (1.29–3.21)
Hypertension 0.054*** 2.46 (0.97–6.26) 0.12 NS
Cardiac (unspecified) 0.002*** 4.21 (1.56–11.36) 0.0068 2.01 (1.08–3.73)
Previous vascular surgery 0.28*** 1.6 (0.63–4.06)
Chronic pulmonary disease 0.14***
Renal insufficiency 0.17***
Smoking 0.18*** 0.48 (0.18–1.31)
*, x2; **, Mann–Whitney-U test; ***, Fisher’s exact test.
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neurological complication (a central, not peripheral,
facial paresis with mild symptoms still at 30 days) in
the control group.
Discussion
This validated audit on CEA covering a whole nation,
demonstrated a perioperative death/permanent
stroke risk well comparable with previous randomised
trials.1–4,7
Population-based studies report complication rates
with wide variation (2.3–7.3%), but differences in
patient selection, study quality and definition of
complications make comparison difficult.8–14 In one
of few national audits Kantonen et al.15 reports a
death/stroke risk of 3.3%, with data based on a nation-
wide vascular registry (Finnvasc)
The Swedish Vascular Registry, which forms the
basis of this report, covers every centre in Sweden
performing CEA. A potential weakness with the
results is the problem of self-reported data.16 Only a
few centres have independent neurological evalu-
ation, but the results of the individual surgeons are
confidential making the risk of bias less.
A previous study has shown an above 90%
report rate and reproducibility concerning all
vascular surgery.5 Patients not included in the
registry have mostly undergone minor procedures,
such as access surgery or embolectomies and been
admitted in other departments.6 So it seems
reasonable to expect an even higher report rate for
CEA.
In the validation process in this series only one
patient with a permanent stroke was found among the
controls (0.77% 1/130), being wrongly reported as a
local neurological complication.
Risk factors in this series were mostly consistent
with several other reports and systematic reviews.17,18
Although age (.75 years) was a risk factor for
perioperative death, other subanalyses19,20 and
reports21 have found an increased long-term relative
survival after CEA in this subgroup, compared with
medical treatment alone.
Minor stroke as a qualifying event for CEA was
found to be a risk factor for permanent stroke and
Table 5. Risk factors for combined perioperative permanent stroke and mortality N 5 65=1518 (4.3%)
Risk factor Univariate analysis Multivariate analysis
P RR (95% confidence interval) p RR (95% confidence interval)
Operation at a university hospital 0.05* 1.67 (0.99–2.83) 0.019 1.39 (1.05–1.83)
Indication (minor stroke vs. other indications) 0.02** 1.41 (1.06–1.87) 0.023 1.38 (1.04–1.83)
Age .75 years 0.09* 1.56 (0.93–2.63) 0.14 NS
Male 0.51* 1.18 (0.71–1.99)
Diabetes 0.09* 2.05 (1.19–3.53) 0.025 1.41 (1.04–1.89)
Hypertension 0.037* 1.69 (1.03–2.78) 0.08 NS
Cardiac (unspecified) 0.005* 1.98 (1.22–2.73) 0.0055 1.43 (1.11–1.86)
Previous vascular surgery 0.13* 1.51 (0.88–2.59)
Chronic pulmonary disease 0.79***
Renal insufficiency 1.0***
Smoking 0.047* 0.58 (0.31–1.00) 0.09 NS
*, x2; **, Mann–Whitney-U test; ***, Fisher’s exact test.
Table 6. Analysed risk factors in case–control study
Risk factor p
Stenosis degree, mean 84.5 ^ 11.8 (SD) range 35–100 0.615*
Contralateral occlusion N ¼ 22 (15 cases vs. 7 controls) 0.00049* OR ¼ 5.27(2.02–13.07)
Infarct on CT preoperatively, N ¼ 83 (30 cases vs. 53 controls) 0.47***
Bleeding in ml, (cases median ¼ 200 range 0–1600; controls
median ¼ 150 range 0–700)
0.16****
Shunt N ¼ 79 (28 cases vs. 51 controls) 0.61***
Occlusion time, min (cases mean ¼ 29.7 ^ 25.6 (SD); controls
mean ¼ 26.65 ^ 21.4 (SD))
0.409*
Operation time, min (cases median ¼ 128 range 60–314; controls
median ¼ 120 range 59–200)
0.18****
Tacking suture at the distal endarterectomy site, N ¼ 67 (24 cases vs.
43 controls)
0.59***
Local anaesthesia vs. general anaesthesia (cases 16 vs 49; controls 39
vs. 91)
0.43***
*, Students-test; **, Fisher’s exact test; ***, x2; ****, Mann–Whitney-U test.
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stroke/death both in uni- and multivariate analysis, in
agreement with many other studies.7,13,22,23
The present study confirmed the increased risk with
comorbidity; diabetes and cardiac disease as well as
previous vascular surgery were independent risk
factors, also described by other investigators.9,20,22,26
Operation at a university hospital was a risk factor
for death and combined death/permanent stroke,
though the indications and risk factors were compar-
able with non-university hospitals. In an audit in
UK/Ireland, McCollum et al. found similar risk
between district general hospitals and university
hospitals, but with an independent increased risk
factor of stroke with a trainee as the first surgeon. Two
possible explanations might be, first that more
surgeons in training perform the operations at a
university hospital, but our data was not surgeon
specific so this hypothesis could not be tested.
Secondly, those patients who were technically
demanding or with atypical indications might have
been referred to university hospitals, which was not
reflected in conventional risk factors.
Much has been written about the correlation
between CEA complications and the surgical volume
of the hospital and individual surgeon. Many report
an increased risk in ‘low-volume’ centres8,12,15,24–26
but others find similar results in ‘low vs. high volume’
centres.14,27 We could not analyse this on individual
surgeons but found no correlation between surgical
volume of the centre and complication rates. The mean
annual caseload was low, with just four of 20 centres
performing .31 CEA/year. However, all centres
operating CEA also performed all other types of
vascular surgery influencing the technical skill.
In the case–control study, the only significant risk
factor was contralateral occlusion, also consistent with
other reports.20,28 Nevertheless, there is strong evi-
dence in favour for CEA for these patients, when
weighted against the risk with medical treatment
alone.29,30 That type of anaesthesia did not influence
outcome in this series.
In conclusion, a validated national vascular registry
(e.g. Swedvasc) is useful in demonstrating population-
based data on operative risk. A combined cohort/-
case–control methodology is helpful in analysing risk
factors for serious perioperative complications. This
national audit of CEA in Sweden, demonstrated
complication rates well comparable with those from
previous randomised trials.
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